We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$8.21B
AUM Growth
+$1.17B
Cap. Flow
+$1.31B
Cap. Flow %
15.93%
Top 10 Hldgs %
19.59%
Holding
1,801
New
278
Increased
701
Reduced
627
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 19.89%
2 Financials 9.29%
3 Industrials 9.2%
4 Healthcare 6.57%
5 Communication Services 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPEI icon
1426
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.91B
$283K ﹤0.01%
+14,920
New +$289K
EXG icon
1427
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.92B
$283K ﹤0.01%
32,718
-92,878
-74% -$872K
TEM
1428
Tempus AI
TEM
$7.97B
$283K ﹤0.01%
6,265
-156
-2% -$8.87K
CACI icon
1429
CACI
CACI
$11.1B
$283K ﹤0.01%
520
+9
+2% +$5.42K
BCAT icon
1430
BlackRock Capital Allocation Term Trust
BCAT
$1.62B
$282K ﹤0.01%
19,964
-30,952
-61% -$456K
TPC
1431
Tutor Perini Cor
TPC
$4.6B
$279K ﹤0.01%
+3,618
New +$277K
CGBL icon
1432
Capital Group Core Balanced ETF
CGBL
$7.01B
$279K ﹤0.01%
8,107
+1,372
+20% +$49.1K
HUBS icon
1433
HubSpot
HUBS
$10.1B
$279K ﹤0.01%
+1,141
New +$320K
VTS icon
1434
Vitesse Energy
VTS
$665M
$278K ﹤0.01%
15,291
-5,485
-26% -$110K
ING icon
1435
ING
ING
$93.8B
$275K ﹤0.01%
10,542
+558
+6% +$15.7K
COPX icon
1436
Global X Copper Miners ETF NEW
COPX
$7.13B
$274K ﹤0.01%
+3,594
New +$298K
LH icon
1437
Labcorp
LH
$24.3B
$274K ﹤0.01%
1,027
IPAR icon
1438
Interparfums
IPAR
$3.85B
$273K ﹤0.01%
+3,000
New +$284K
MD icon
1439
Pediatrix Medical
MD
$2.16B
$271K ﹤0.01%
12,654
-500
-4% -$10.4K
PSI icon
1440
Invesco Semiconductors ETF
PSI
$2.49B
$269K ﹤0.01%
2,847
-1,693
-37% -$161K
GVIP icon
1441
Goldman Sachs Hedge Industry VIP ETF
GVIP
$553M
$269K ﹤0.01%
1,843
+453
+33% +$70.2K
TECH icon
1442
Bio-Techne
TECH
$11.2B
$268K ﹤0.01%
5,132
-219
-4% -$13.1K
SLGN icon
1443
Silgan Holdings
SLGN
$4.85B
$267K ﹤0.01%
6,880
WTFC icon
1444
Wintrust Financial
WTFC
$10.6B
$265K ﹤0.01%
1,909
-40
-2% -$5.8K
BILS icon
1445
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.84B
$264K ﹤0.01%
+2,650
New +$263K
VTIP icon
1446
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$263K ﹤0.01%
5,275
-1,430
-21% -$71.1K
EWU icon
1447
iShares MSCI United Kingdom ETF
EWU
$4.04B
$263K ﹤0.01%
5,773
+18
+0.3% +$829
GTOP
1448
Goldman Sachs Technology Opportunities ETF
GTOP
$702M
$263K ﹤0.01%
7,263
SPHY icon
1449
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.4B
$261K ﹤0.01%
11,202
-5,016
-31% -$118K
ASPN icon
1450
Aspen Aerogels
ASPN
$409M
$261K ﹤0.01%
76,284
-737
-1% -$2.48K

Similar funds

Oppenheimer & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Oppenheimer & Co held 1,801 positions worth $8.21B, up 17% from $7.04B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co deployed $1.31B of net new capital in Q1 2026, opening 278 new positions and adding to 701 existing holdings. Its largest new stake was Apple: 1,107,179 shares worth $281M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $11.2M trimmed.

  • Oppenheimer & Co's largest Q1 2026 buy was Apple: 1,107,179 shares worth $281M.
  • Oppenheimer & Co added most to Microsoft in Q1 2026, an estimated $24M increase.
  • Oppenheimer & Co's biggest Q1 2026 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $11.2M.
  • Oppenheimer & Co fully exited Telefonica in Q1 2026, selling an estimated $6.36M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $8.21B portfolio in Q1 2026.
  • Oppenheimer & Co opened 278 new positions and closed 118 in Q1 2026.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $8.21B.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.